Ghent University Academic Bibliography

Show Sort by

Your filters: cql: publisher exact "AMER SOC HEMATOLOGY"

Add to list
- Journal Article
- A1
Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival

Mohamed Lamkanfi (UGent) , LO Moreira, P Makena, DCJ Spierings, K Boyd, PJ Murray, DR Green and TD Kanneganti

(2009) BLOOD. 113(12). p.2742-2745
Add to list
Reconstitution of protection against Aspergillus infection in chronic granulomatous disease (CGD)

Quinten Remijsen (UGent) , Peter Vandenabeele (UGent) , Jean Willems and Taco Kuijpers

(2009) BLOOD. 114(16). p.3497-3497
Add to list
Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamine-induced E-cadherin/catenin complexes

J Van den Bossche, Pieter Bogaert (UGent) , Jolanda van Hengel (UGent) , Chris Guerin (UGent) , Geert Berx (UGent) , K Movahedi, R Van den Bergh, A Pereira-Fernandes, JMC Geuns, H Pircher, et al.

(2009) BLOOD. 114(21). p.4664-4674
Add to list
Ly49E-dependent inhibition of natural killer cells by urokinase plasminogen activator

Tina Van Den Broeck (UGent) , Frederick Stevenaert, Sylvie Taveirne (UGent) , Veronique Debacker (UGent) , CHRISTEL VANGESTEL, Bart Vandekerckhove (UGent) , Tom Taghon (UGent) , Patrick Matthys, Jean Plum (UGent) , Werner Held, et al.

(2008) Blood. 112(13). p.5046-5051
Add to list
- Journal Article
- A1
Notch signaling induces cytoplasmic CD3 epsilon expression in human differentiating NK cells

Magda De Smedt (UGent) , Tom Taghon (UGent) , Inge Van de Walle (UGent) , Greet De Smet (UGent) , Georges Leclercq (UGent) and Jean Plum (UGent)

(2007) BLOOD. 110(7). p.2696-2703
Add to list
Distinct roles of Mdm2 and Mdm4 in red cell production

Marion Maetens, Gilles Doumont, Sarah De Clercq (UGent) , Sarah Francoz, P FROMENT, E BELLEFROID, U KLINGMULLER, G LOZANO and Jean-Christophe Marine (UGent)

(2007) BLOOD. 109(6). p.2630-2633
Add to list
- Conference Paper
- C3
Endothelial cells are not derived from hematopoietic precursor cells

Frank Timmermans (UGent) , Magda De Smedt (UGent) , Robrecht Raedt (UGent) , Jean Plum (UGent) and Bart Vandekerckhove (UGent)

(2006) BLOOD. 108(11).
Add to list
- Journal Article
- A1
Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia

F CORAZZA, C HERMANS, S D'HONDT, A FERSTER, A KENTOS, Yves Benoit (UGent) and E SARIBAN

(2006) BLOOD. 107(6). p.2525-2530
Add to list
- Journal Article
- A1
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

S CHOQUET, V LEBLOND, R HERBRECHT, G SOCIE, AM STOPPA, P VANDENBERGHE, A FISCHER, F MORSCHHAUSER, G SALLES, W FEREMANS, et al.

(2006) BLOOD. 107(8). p.3053-3057
Add to list
- Journal Article
- A1
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

R MARCUS, K IMRIE, A BELCH, D CUNNINGHAM, E FLORES, J CATALANO, P SOLAL-CELIGNY, Fritz Offner (UGent) , J WALEWSKI, J RAPOSO, et al.

(2005) BLOOD. 105(4). p.1417-1423

Academic Bibliography

Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival

Reconstitution of protection against Aspergillus infection in chronic granulomatous disease (CGD)

Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamine-induced E-cadherin/catenin complexes

Ly49E-dependent inhibition of natural killer cells by urokinase plasminogen activator

Notch signaling induces cytoplasmic CD3 epsilon expression in human differentiating NK cells

Distinct roles of Mdm2 and Mdm4 in red cell production

Endothelial cells are not derived from hematopoietic precursor cells

Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

Contents

Support

Contact